Technology
Health
Biotechnology
Neurocrine
$87.629876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$87.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.81 (3.31%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Neurocrine and other stocks, options, ETFs, and crypto commission-free!
About
Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. Read More The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.
Employees
585
Headquarters
San Diego, California
Founded
1992
Market Cap
7.70B
Price-Earnings Ratio
485.16
Dividend Yield
0.00
Average Volume
862.71K
High Today
$87.70
Low Today
$84.97
Open Price
$85.03
Volume
444.33K
52 Week High
$126.98
52 Week Low
$64.72
Collections
Technology
Health
Biotechnology
Pharmaceutical
US
North America
News
Seeking Alpha14h
Neurocrine Biosciences: Rapid Pipeline Expansion Underway
Since my earlier article, Neurocrine Biosciences (NBIX) shares have retreated quite a bit off all time highs in September 2018. The safety scare was the first major selloff on elevated volume as an increase in reported deaths caused a panic, sending shares down over 10% one day in November.
Yahoo FinanceMar 15
CTLT or NBIX: Which Is the Better Value Stock Right Now?
CTLT vs. NBIX: Which Stock Is the Better Value Option? Investors interested in stocks from the Medical - Drugs sector have probably already heard of Catalent (CTLT) and Neurocrine Biosciences (NBIX). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores syst...
Price Paid on Robinhood
1% Higher
Right Now
52 Week Low
$64.72
Average Price Paid
$86.40
52 Week High
$126.98
Earnings
-$0.68
-$0.28
$0.12
$0.52
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected Apr 29, After Hours